Anti-programmed Cell Death Protein-1 Therapy in Intrahepatic Cholangiocarcinoma Induced Type 1 Diabetes: A Case Report and Literature Review

Immune checkpoint inhibitors, widely used in the treatment of malignancies, can improve the prognosis of patients, while it also can induce various immune-related adverse events, and type 1 diabetes induced by anti-programmed cell death protein-1 is a rare but severe complication. Here we reported a...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhi-Kai, Wang, Jiong-Liang, Li, Wen-Xuan, Wu, Tian-Qing, Chen, Min-Shan, Zhou, Zhong-Guo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Public Health
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243496/
https://www.ncbi.nlm.nih.gov/pubmed/35784237
http://dx.doi.org/10.3389/fpubh.2022.917679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243496/
https://www.ncbi.nlm.nih.gov/pubmed/35784237
http://dx.doi.org/10.3389/fpubh.2022.917679

Ejemplares similares